SynthesisEuropean journal of medical research2024

The efficacy of tixagevimab/cilgavimab (Evusheld) in prophylaxis and treatment of COVID-19 in immunocompromised patients: a systematic review and meta-analysis.

Shaymaa Glhoom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.